Johnson & Johnson (JNJ) Net Income (2009 - 2026)
Johnson & Johnson (JNJ) posted Net Income of $5.5 billion for Q2 2026, up 5.71% sequentially from $5.2 billion in Q1 2026, and little changed YoY from $5.5 billion in Q2 2025.
Johnson & Johnson (JNJ) Net Income (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Net Income for 17 years, with the latest figure at $5.5 billion in Q2 2026.
- Quarterly Net Income changed 0.05% year-over-year to $5.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.0 billion (up 27.22% YoY) and the FY2023 annual result came in at $21.8 billion, up 1289.37% from the prior year.
- Net Income advanced to $5.5 billion in Q2 2026 per JNJ's latest filing, from $5.2 billion in the prior quarter.
- Over five years, Net Income peaked at $21.7 billion in Q4 2023 and troughed at -$232.0 million in Q3 2023.
- A 4-year average of $4.4 billion and a median of $2.8 billion in 2022 frame the typical range for Net Income.
- The widest YoY moves for Net Income: up 14575.0% in 2023, down 142.03% in 2023.
- Over 4 years, Net Income stood at $148.0 million in 2022, then plunged by 156.08% to -$83.0 million in 2023, then soared by 6263.86% to $5.1 billion in 2025, then gained by 8.17% to $5.5 billion in 2026.
- According to Business Quant data, Net Income over the past three periods registered $5.5 billion, $5.2 billion, and $5.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -238.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 207.96 Mn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 17.71 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 5.53 Bn |
| Mar 29, 2026 | 5.24 Bn |
| Dec 28, 2025 | 5.12 Bn |
| Sep 28, 2025 | 5.15 Bn |
| Jun 29, 2025 | 5.54 Bn |
| Mar 30, 2025 | 11.00 Bn |
| Dec 31, 2023 | -83.00 Mn |
| Oct 1, 2023 | 21.72 Bn |
| Jul 2, 2023 | -232.00 Mn |
| Apr 2, 2023 | 423.00 Mn |
| Jan 1, 2023 | 293.00 Mn |
| Oct 2, 2022 | 148.00 Mn |
| Jul 3, 2022 | 552.00 Mn |
| Apr 3, 2022 | 578.00 Mn |
| Oct 3, 2021 | 3.67 Bn |
| Jul 4, 2021 | 6.28 Bn |
| Apr 4, 2021 | 6.20 Bn |
| Jan 3, 2021 | 1.74 Bn |
| Sep 27, 2020 | 3.55 Bn |
| Jun 28, 2020 | 3.63 Bn |